ReShape Lifesciences Inc. (RSLS)
NASDAQ: RSLS
· Real-Time Price · USD
3.92
0.72 (22.50%)
At close: Aug 14, 2025, 3:59 PM
ReShape Lifesciences Fail-to-Deliver
Total FTD Shares
2.95K
Below Average
FTD / Avg. Volume
0.33%
Low Impact
1-Year Change
-86.6%
Negative Trend
FTD Chart
As of Jul 14, 2025,
ReShape Lifesciences Inc. has
2,952
shares failed to deliver, representing 0.33%
of the average daily volume of
884,118
shares. Over the past year, the monthly average FTD is
121,385
shares, with the current level 98% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 2.39 | 2.95K | -94.14% |
Jun 30, 2025 | 2.44 | 50.34K | +6446.42% |
May 30, 2025 | 4.91 | 769 | -34.61% |
Apr 25, 2025 | 9.13 | 1.18K | -93.28% |
Mar 31, 2025 | 9.01 | 17.5K | +20.00% |
Feb 28, 2025 | 25.75 | 14.58K | +32297.78% |
Jan 30, 2025 | 94.25 | 45 | -93.28% |
Dec 31, 2024 | 111.5 | 670 | +998.36% |
Nov 26, 2024 | 142 | 61 | -98.84% |
Oct 31, 2024 | 141.25 | 5.26K | -91.32% |
Sep 30, 2024 | 141.25 | 60.56K | +101.22% |
Aug 30, 2024 | 233.5 | 30.09K | +57775.00% |
Jul 30, 2024 | 290.25 | 52 | +126.09% |
Jun 28, 2024 | 277.75 | 23 | -100.00% |
May 31, 2024 | 369.5 | 4.73M | +19623.29% |
Apr 30, 2024 | 240.75 | 23.99K | -80.03% |
Mar 28, 2024 | 267.5 | 120.15K | +4770.37% |
Feb 29, 2024 | 244 | 2.47K | -40.45% |
Jan 31, 2024 | 303.25 | 4.14K | -40.80% |
Dec 29, 2023 | 362 | 7K | -56.28% |
Nov 20, 2023 | 333.75 | 16.01K | -76.48% |
Oct 31, 2023 | 356.75 | 68.04K | +715.84% |
Sep 29, 2023 | 490 | 8.34K | +22440.54% |
Aug 04, 2023 | 2102.5 | 37 | -98.34% |
Jul 31, 2023 | 2059 | 2.23K | +219.00% |
Jun 30, 2023 | 2146 | 700 | -72.48% |
May 31, 2023 | 3509 | 2.54K | +6.35% |
Apr 28, 2023 | 3291.5 | 2.39K | +3758.06% |
Mar 31, 2023 | 3726.5 | 62 | -96.89% |
Feb 24, 2023 | 5843.5 | 1.99K | +1374.81% |
Jan 31, 2023 | 10498 | 135 | n/a |